Bioengineered Bacteria Turn Tumor Fuel into Electricity to Zap Cancer Cells from Within
Evidence review & editorial synthesis
Treating solid tumors that resist standard immunotherapies, often classified as immunologically cold cancers, remains one of the greatest challenges in modern oncology. These tumors create a metabolic fortress around themselves, accumulating high levels of lactate while suppressing the body's immune defenses. Now, a study published in Advanced Materials reveals an unconventional strategy: using bioengineered living bacteria to infiltrate the tumor microenvironment, hijack its lactate fuel, and convert it into a localized bioelectric current that destroys cancer cells.
Developed by a multidisciplinary team of biomedical researchers, the platform, termed PSDT, combines synthetic biology, nanomedicine, and bioelectronics. At its core is Shewanella, a species of bacteria naturally capable of extracellular electron transfer, modified with palladium-platinum (Pd/Pt) nanoparticles and shielded by a reactive oxygen species (ROS)-responsive polymer shell. This polymer shield keeps the engineered bacteria completely inert while circulating in the body, ensuring safety until they reach their targeted destination.
Establishing the Microscopic Bioelectric Synapse
The activation process relies on precise spatial timing. When low-dose radiotherapy is directed at the target site, radiation triggers the release of ROS within the tumor. This breaks down the protective polymer shell, releasing the active bacterial core specifically inside the cancerous tissue. Once liberated, the anaerobic bacteria thrive in the low-oxygen environment of the solid tumor.
Upon activation, the bacteria extend conductive biological nanowires that physically connect to nearby cancer cell membranes, establishing functional electronic synapses. Simultaneously, the biomineralized Pd/Pt bio-alloy dramatically enhances the bacteria's ability to metabolize tumor lactate. By consuming the excess lactate, the bacteria generate a continuous stream of bioelectric current. When combined with radiation-induced high-energy electron release, this dual pathway delivers targeted electrical ablation directly into the cancer cells without harming adjacent healthy tissue.
Sparking a Systemic Immune Response
In addition to direct cellular destruction, the bioelectric ablation process breaks down the tumor's physical defenses. As cancer cells undergo electro-ablation and bacterial disruption occurs, tumor-specific antigens and microbial signals are released directly into the local tissue. This sudden release converts the immunologically cold environment into a hotbed of immune activity.
In preclinical testing, this combined electrical and biological disruption triggered a powerful systemic immune response known as an abscopal effect, where immune cells began recognizing and attacking untreated distant tumor sites. When researchers paired the PSDT platform with standard anti-PD-1 checkpoint inhibitor immunotherapy, the treatment achieved durable tumor control and near-complete tumor eradication in preclinical models.
The Horizon for Living Bioelectronics
While these findings represent a leap forward in bioengineering, the technology remains in the early preclinical stage. Further research is required to optimize manufacturing standards, evaluate long-term biological safety, and establish precise dosing protocols before human clinical trials can begin.
Nevertheless, the concept of using living organisms as self-powered bioelectronic devices opens a new avenue in targeted therapeutics. By turning a cancer cell's metabolic waste into the very electricity that destroys it, researchers have laid the groundwork for intelligent therapeutics that combine targeted bioelectric ablation with systemic immunotherapy.
Scientific References & Further Reading
- Anchor Study: “Biomineralized Shewanella Exploits Tumor Lactate Metabolism via Biological Nanowires for Radiotherapy-Synergized Bioelectric Ablation and Systemic Immunity.” (Guo, M., Xu, W., Sun, P., Liu, J., Hao, X., Li, M., Huang, H., & Liao, D. (2026). Biomineralized Shewanella Exploits Tumor Lactate Metabolism via Biological Nanowires for Radiotherapy-Synergized Bioelectric Ablation and Systemic Immunity. Advanced Materials, 38(30), e74300. doi:10.1002/adma.74300.)
Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not a substitute for diagnosis, treatment, or individualized medical care.